Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades.
Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S. Yanada M, et al. Among authors: maeda t. Bone Marrow Transplant. 2019 Apr;54(4):578-586. doi: 10.1038/s41409-018-0301-7. Epub 2018 Aug 14. Bone Marrow Transplant. 2019. PMID: 30108330
Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
Mori T, Koh H, Onishi Y, Kako S, Onizuka M, Kanamori H, Ozawa Y, Kato C, Iida H, Suzuki R, Ichinohe T, Kanda Y, Maeda T, Nakao S, Yamazaki H. Mori T, et al. Among authors: maeda t. Int J Hematol. 2016 Apr;103(4):461-8. doi: 10.1007/s12185-016-1960-z. Epub 2016 Feb 24. Int J Hematol. 2016. PMID: 26910242
Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis.
Kako S, Fujiwara S, Sato M, Kimura SI, Nakasone H, Ohashi K, Kawakita T, Maeda T, Morishita T, Suzuki R, Fukuda T, Ichinohe T, Kurata M, Atsuta Y, Kanda Y. Kako S, et al. Among authors: maeda t. Biol Blood Marrow Transplant. 2018 Oct;24(10):2139-2144. doi: 10.1016/j.bbmt.2018.04.015. Epub 2018 Apr 19. Biol Blood Marrow Transplant. 2018. PMID: 29680515 Free article. Clinical Trial.
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation.
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R. Fujimoto A, et al. Among authors: maeda t. Biol Blood Marrow Transplant. 2019 Jul;25(7):1441-1449. doi: 10.1016/j.bbmt.2019.02.016. Epub 2019 Feb 20. Biol Blood Marrow Transplant. 2019. PMID: 30794929 Free article. Clinical Trial.
Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.
Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka KI, Miyamoto T, Iida H, Ikegame K, Fukuda T, Ichinohe T, Atsuta Y, Mori T; Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation. Kako S, et al. Among authors: maeda t. Biol Blood Marrow Transplant. 2020 Mar;26(3):445-450. doi: 10.1016/j.bbmt.2019.10.004. Epub 2019 Oct 13. Biol Blood Marrow Transplant. 2020. PMID: 31618688 Free article.
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.
Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.
Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y. Ueda T, et al. Among authors: maeda t. Int J Hematol. 2019 Feb;109(2):197-205. doi: 10.1007/s12185-018-2562-8. Epub 2018 Nov 17. Int J Hematol. 2019. PMID: 30448938
Autoimmune-mediated thrombocytopenia after allogeneic hematopoietic stem cell transplantation: significance of detecting reticulated platelets and glycoprotein-specific platelet autoantibodies.
Akuta K, Fukushima K, Nakata K, Hayashi S, Toda J, Shingai Y, Tsutsumi K, Machida T, Hino A, Kusakabe S, Doi Y, Fujita J, Kato H, Maeda T, Yokota T, Tomiyama Y, Hosen N, Kashiwagi H. Akuta K, et al. Among authors: maeda t. Int J Hematol. 2022 Mar;115(3):322-328. doi: 10.1007/s12185-021-03272-x. Epub 2022 Jan 17. Int J Hematol. 2022. PMID: 35037230
5,616 results